<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pravastatin improves outcome in hypercholesterolemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pravastatin improves outcome in hypercholesterolemia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Pravastatin improves outcome in hypercholesterolemia</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Probability (in percent) of a cardiovascular event in patients with a plasma cholesterol concentration between 200 and 300 mg/dL (5.2 to 6.2 mmol/L) and two additional coronary risk factors who were treated with placebo or pravastatin. Pravastatin diminished the incidence of cardiovascular events, a benefit that was demonstrated within six months.</div><div class="graphic_reference">Data from: Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients. Am J Cardiol 1993; 72:1031.</div><div id="graphicVersion">Graphic 62070 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
